Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PANDA Realizes Continued Process Verification in Pharmaceutical Manufacturing
  • USA - English


News provided by

Atris Information Systems GmbH

Mar 19, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Freiburg, Germany (PRWEB) March 19, 2015 -- The EMA and FDA demand high transparency, verifiability at any time and complete documentation of the life cycle of every single pharmaceutical product. The manufacturing process must be permanently under control and any procedural deviations have to be recognized at the very moment they occur. The procedure allowing this is called Continued Process Verification by the FDA and Continuous Process Verification by the EMA.

The implementation of the CPV represents an enormous challenge for the pharmaceutical industry, whose details and standards in many respects still have to be worked out. Already after the first drafts of the new FDA Guidance on Process Validation in 2008, a forward-thinking pharmaceutical company started the development of a database system with the automated integration of different source systems and statistical software with which valuable experience was gained. This development work led to the now mature system PANDA.

THE REQUIREMENTS OF CONTINUED PROCESS VERIFICATION
The implementation of the Continued Process Verification demands the continuous collection and processing of the data of diverse parameters, such as the Critical Quality Attributes (CQA) and the Critical Process Parameters (CPP) in periodic data analyses.

Continuous reporting to the authorities is required, which can be achieved through quality and process reports (similar to the Annual Process Report) at regular intervals (e.g. monthly). In the data analyses, methods of statistical analysis such as trending, control charts or CpK (Process Capability Index) calculations should therefore be used where possible. The manual and product-oriented data transfer from LIMS systems and process data systems such as EBR (Electronic Batch Records) or BDE (“Betriebsdatenerfassung”/ production data acquisition) and their aggregation (e.g. on Excel sheets) are no longer suitable for Continuous Process Verification due to the increased amount of data and complexity.

In addition to minimizing risk and enormous cost reduction, the database-driven system for process analysis offers the further advantage that its scope goes far beyond the creation of regular and comprehensive reports. Once the data is in a structured form with dedicated access options, it can be used for complex purposes (such as Process Improvement).

PANDA PROVIDES THE SOLUTION FOR THE CPV
In order to realize the Continued Process Verification and its complex tasks, Atris Information Systems – in close collaboration with Boehringer Ingelheim – has developed the standardized system PANDA.

PANDA is an integrated database system, processing and providing information from different source systems. With PANDA raw material, drug data, development data, process data and machine data as well as ERP data can be networked, structured and aggregated. PANDA allows the monitoring of CQA and CPP using trending and statistical analyses over long periods of time.

THE CYCLIC PANDA PROCESS
The PANDA process consists of five steps. In a first step, the different raw material, laboratory and machine process data with the associated metadata is imported into the system under the fullest satisfaction of all requirements for data integrity. Subsequently, a harmonization of the data takes place. This central function of the system only creates the conditions for being able to correlate the individual parameters. The user of the system then has the possibility to define data grids and parameters and thus obtain individual evaluations. In a next step the aggregation and analysis of the data is carried out.

At the end of the process, the results can be presented by using pattern reports. The data is kept automatically up to date by the import cycle, whereas reports can be accessed in an actualized version at any time.

PANDA PRIVATE CLOUD
The PANDA private cloud service adds another feature with numerous user advantages. In addition to the now widely known benefits of the private cloud, the company offers advisory services for statistical processing and know-how in the GMP environment. The requirements of the FDA and EMA for dealing with CPP and CQA data can be realized perspicuously in this way. The costs of the installation, validation and maintenance can be reduced by keeping full back-up service and data security and benefiting from synergy effects. In a professional environment at the technological forefront, Big Data Management and Process Verification become reliable, traceable and safe.

CONCLUSION
With PANDA, the result of the practical experience and development in recent years, a fully deployable solution for Continued Process Verification is available. PANDA offers numerous options for individual configurations by the user in terms of parameters, the evaluations and reports, and thereby represents a surplus for each pharmaceutical company.

ABOUT ATRIS:
Atris Information Systems GmbH is specialized in quality-assuring data processing and evaluation (business intelligence, trending, and data mining) in the pharmaceutical and chemical industry as well as in project and system validation in the GMP domain (research, production and quality assurance).

----------------------------------------
Footnote:
1 Guideline on process validation for finished products – information and data to be provided in regulatory submissions – February 27, 2014
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500162136.pdf
2 Guidance for Industry – Process validation: general principles and practices – January 2011
http://www.fda.gov/downloads/Drugs/Guidances/UCM070336.pdf
3 See also http://www.atris-systems.com/172.0.html

Peter Trochim, Atris Information Systems GmbH, http://www.atris-systems.com, +49 761 47 99 5920, [email protected]

Modal title

Data integration, Processing and Process analysis with PANDA
Data integration, Processing and Process analysis with PANDA
Data integration, Processing and Process analysis with PANDA

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.